Daniel J. Lindner, MD, PhD

Assistant Professor
Department of Molecular Medicine
School of Medicine
Member
Developmental Therapeutics Program
Case Comprehensive Cancer Center

Research Information

Research Projects

Dr. Lindner’s research involves the study of mechanisms of acquired drug resistance in renal cancer, and development of more effective drugs to treat myelodysplastic syndrome and acute myelogenous leukemia.  His research in the Athymic Animal & Xenograft Core Facility at CWRU deals with utilizing human and mouse tumor models, angiogenesis (growth of blood vessels stimulated by tumors) and pharmacokinetics (the movement and metabolism of drugs in the body). Animal experiments are routinely conducted in the Athymic Animal & Xenograft Core, including research on mouse and human tumor models.

External Appointments

Associate Staff, Center for Hematology and Oncology Molecular Therapeutics
Taussig Cancer Institute, Cleveland Clinic
Associate Staff, Department of Cancer Biology
Lerner Research Institute, Cleveland Clinic

Publications

Additional Information

Daniel J. Lindner has been pulled and future remote updates would overwrite local changes.
You can override this to make sure that future remote updates will be ignored so your local changes persist.
Resetting this later will immediately reset all local changes.
If the remote content is deleted, this content will also be deleted locally and your local changes will be lost.